ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 86 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,322,713 | -22.5% | 198,011 | -2.7% | 0.00% | -100.0% |
Q2 2023 | $1,706,853 | +19.8% | 203,439 | +41.8% | 0.00% | – |
Q1 2023 | $1,424,279 | +45.9% | 143,432 | +2.3% | 0.00% | – |
Q4 2022 | $976,000 | +378.4% | 140,232 | +267.1% | 0.00% | – |
Q3 2022 | $204,000 | +110.3% | 38,200 | +57.9% | 0.00% | – |
Q2 2022 | $97,000 | -29.2% | 24,200 | -21.4% | 0.00% | – |
Q1 2022 | $137,000 | +11.4% | 30,800 | 0.0% | 0.00% | – |
Q4 2021 | $123,000 | -69.5% | 30,800 | -32.9% | 0.00% | – |
Q3 2021 | $403,000 | -21.0% | 45,900 | -0.2% | 0.00% | – |
Q2 2021 | $510,000 | +79.6% | 46,000 | +92.5% | 0.00% | – |
Q1 2021 | $284,000 | -73.7% | 23,900 | -84.8% | 0.00% | – |
Q4 2020 | $1,081,000 | -38.4% | 157,558 | -33.4% | 0.00% | -100.0% |
Q3 2020 | $1,754,000 | +2207.9% | 236,674 | +1182.6% | 0.00% | – |
Q2 2020 | $76,000 | -91.4% | 18,453 | -82.6% | 0.00% | – |
Q4 2018 | $879,000 | -23.2% | 105,967 | +27.9% | 0.00% | – |
Q3 2018 | $1,144,000 | – | 82,882 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 473,446 | $5,625,000 | 4.61% |
Knoll Capital Management, LLC | 569,405 | $6,765,000 | 4.41% |
SILVERARC CAPITAL MANAGEMENT, LLC | 321,879 | $3,824,000 | 2.09% |
First Light Asset Management, LLC | 2,624,001 | $31,173,000 | 2.07% |
Mesirow Financial Investment Management, Inc. | 63,634 | $756,000 | 2.06% |
Ghost Tree Capital, LLC | 650,000 | $7,722,000 | 1.82% |
Altium Capital Management LP | 548,225 | $6,513,000 | 1.81% |
Perceptive Advisors | 8,703,879 | $103,402,000 | 1.31% |
Affinity Asset Advisors, LLC | 300,000 | $3,564,000 | 1.21% |
Avidity Partners Management LP | 2,552,000 | $30,318,000 | 0.84% |